India’s Bharat Biotech’s nasal COVID-19 vaccine advances into next stage of trials August 13, 2021 Auto Bot News 0 Early stage trials of the vaccine candidate, BBV154, has been completed in subjects aged 18 to 60 years, and the doses were found to be well tolerated, the statement said.